This topic contains a solution. Click here to go to the answer

Author Question: The second demographic transition in Europe is defined by: a. a new family movement. b. rising ... (Read 57 times)

mrsjacobs44

  • Hero Member
  • *****
  • Posts: 500
The second demographic transition in Europe is defined by:
 
  a. a new family movement.
  b. rising population within the European Union caused by generous state benefits.
  c. the integration of markets for selling their products.
  d. the decline in fertility to a level well below replacement.
  e. the use of technology to improve fecundity.

Question 2

economies are center around a few commodities, or even a single commodity.
 
  a. Core
  b. Peripheral
  c. Semiperipheral
  d. Industrial



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

heinisk01

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

D

Answer to Question 2

b




mrsjacobs44

  • Member
  • Posts: 500
Reply 2 on: Jul 1, 2018
Excellent


JCABRERA33

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library